A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

Clinical trial NCT00305448 · COMPLETED

Trial details

NCT number: NCT00305448
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2006-03-01
Primary completion: 2008-03-01
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.